<DOC>
	<DOCNO>NCT01722409</DOCNO>
	<brief_summary>The investigator design double-blind , randomize placebo-controlled study determine effect dexmedetomidine recovery characteristic patient schedule undergo endovascular coil embolization .</brief_summary>
	<brief_title>A Better Choice Patients Undergoing Endovascular Coil Embolization</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Sevoflurane</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>1865 year old ASA I ASA II patient undergo ECE treatment intracranial aneurysm include . Patients exclude base follow parameter : old 65 yr , history mental illness , recent use sedatives analgesic sensation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>dexmedetomidine , endovascular coil embolization</keyword>
</DOC>